dichlorphenamide has been researched along with Familial Hypokalemic Periodic Paralysis in 4 studies
Dichlorphenamide: A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
diclofenamide : A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In one study dichlorphenamide (DCP) vs placebo was tested in two groups of participants: 42 with hypokalemic periodic paralysis (HypoPP) and 31 with hyperkalemic periodic paralysis (HyperPP), based on clinical criteria." | 4.84 | Treatment for periodic paralysis. ( Links, TP; Meola, G; Panzeri, M; Rose, MR; Sansone, V, 2008) |
| "Oral dichlorphenamide (Keveyis™) is a carbonic anhydrase inhibitor that is approved in the USA for the treatment of primary hyperkalaemic and hypokalaemic periodic paralyses and related variants." | 2.53 | Dichlorphenamide: A Review in Primary Periodic Paralyses. ( Greig, SL, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fontaine, B | 1 |
| Phillips, LH | 1 |
| Greig, SL | 1 |
| Sansone, V | 1 |
| Meola, G | 1 |
| Links, TP | 1 |
| Panzeri, M | 1 |
| Rose, MR | 1 |
2 reviews available for dichlorphenamide and Familial Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
Dichlorphenamide: A Review in Primary Periodic Paralyses.
Topics: Carbonic Anhydrase Inhibitors; Clinical Trials, Phase III as Topic; Cross-Over Studies; Dichlorphena | 2016 |
Treatment for periodic paralysis.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Dichlorphenamide; Humans; Hypokalemic Periodic Paralys | 2008 |
2 other studies available for dichlorphenamide and Familial Hypokalemic Periodic Paralysis
| Article | Year |
|---|---|
A newly approved drug for a rare group of diseases: Dichlorphenamide for periodic paralysis.
Topics: Dichlorphenamide; Humans; Hypokalemic Periodic Paralysis; Paralyses, Familial Periodic; Paralysis | 2016 |
Dichlorphenamide (Keveyis) for periodic paralysis.
Topics: Carbonic Anhydrase Inhibitors; Dichlorphenamide; Drug Administration Schedule; Drug Costs; Drug Inte | 2016 |